The latest price target for IDEAYA Biosciences (NASDAQ:IDYA) was reported by Wedbush on September 24, 2024. The analyst firm set a price target for $52.00 expecting IDYA to rise to within 12 months (a possible 70.49% upside). 31 analyst firms have reported ratings in the last year.

The latest analyst rating for IDEAYA Biosciences (NASDAQ:IDYA) was provided by Wedbush, and IDEAYA Biosciences maintained their outperform rating.

The last upgrade for IDEAYA Biosciences Inc happened on April 24, 2023 when Stifel raised their price target to $24. Stifel previously had a hold for IDEAYA Biosciences Inc.

The last downgrade for IDEAYA Biosciences Inc happened on August 15, 2022 when Stifel changed their price target from $16 to $13 for IDEAYA Biosciences Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of IDEAYA Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for IDEAYA Biosciences was filed on September 24, 2024 so you should expect the next rating to be made available sometime around September 24, 2025.

While ratings are subjective and will change, the latest IDEAYA Biosciences (IDYA) rating was a maintained with a price target of $54.00 to $52.00. The current price IDEAYA Biosciences (IDYA) is trading at is $30.50, which is out of the analyst’s predicted range.